Limb-girdle muscular dystrophy type 2D gene therapy restores α-sarcoglycan and associated proteins-Reference-Cited by-同舟云学术

Limb-girdle muscular dystrophy type 2D gene therapy restores α-sarcoglycan and associated proteins

Published:2009-09 Issue:3 Volume:66 Page:290-297
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Mendell Jerry R.,Rodino-Klapac Louise R.,Rosales-Quintero Xiomara,Kota Janaiah,Coley Brian D.,Galloway Gloria,Craenen Josepha M.,Lewis Sarah,Malik Vinod,Shilling Christopher,Byrne Barry J.,Conlon Thomas,Campbell Katherine J.,Bremer William G.,Viollet Laurence,Walker Christopher M.,Sahenk Zarife,Clark K. Reed

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.21732/fullpdf

Reference25 articles.

1. Sarcoglycan subcomplex in normal and pathological human muscle fibers;Anastasi;Eur J Histochem,2007

2. Molecular and cell biology of the sarcoglycan complex;Ozawa;Muscle Nerve,2005

3. Limb-girdle muscular dystrophies-from genetics to molecular pathology;Laval;Neuropathol Appl Neurobiol,2004

4. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?;Klinge;Neuromuscul Disord,2008

5. A common missense mutation in the adhalin gene in three unrelated Brazilian families with a relatively mild form of autosomal recessive limb-girdle muscular dystrophy;Bueno;Hum Mol Genet,1995

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced therapeutic approaches in sarcoglycanopathies;Current Opinion in Pharmacology;2024-06

2. Newborn Screening for Neuromuscular Disorders, Disorders of Glycogen Metabolism, and Fatty Acid Oxidation;OBM Genetics;2024-04-18

3. Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study;BMC Neurology;2024-03-15

4. The Importance of Early Treatment of Inherited Neuromuscular Conditions;Journal of Neuromuscular Diseases;2024-03-05

5. Detection of Humoral Response to Transgene Protein and Gene Editing Reagents;Drug Development for Gene Therapy;2024-02-16